Dérivés de Quinazoline et de Quinoléine
Les quinazolines et les quinoléines sont des composés hétérocycliques azotés à structure aromatique qui jouent un rôle clé dans la synthèse de médicaments à activité anticancéreuse, antimicrobienne et anti-inflammatoire. Leurs dérivés présentent des modifications structurelles qui optimisent leur biodisponibilité et leur sélectivité, permettant ainsi le développement de nouveaux principes actifs pour diverses applications thérapeutiques. Ces composés sont utilisés dans la fabrication d’API destinés au traitement du cancer, des infections, des maladies neurodégénératives et cardiovasculaires. De plus, les dérivés de quinazoline et de quinoléine sont essentiels dans la recherche d’inhibiteurs enzymatiques et dans la conception de molécules bioactives innovantes.
Chez CymitQuimica, nous proposons des dérivés de quinazoline et de quinoléine de haute pureté pour des applications en synthèse chimique, développement pharmaceutique et biotechnologie.
65630 produits trouvés pour "Dérivés de Quinazoline et de Quinoléine"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Topiramate N-methyl impurity
CAS :<p>Topiramate is a drug used to treat epilepsy and weight loss. The N-methyl impurity is a synthetic compound that is an impurity in the drug product. The impurity was synthesized by reacting 4-hydroxybenzaldehyde with methylamine in the presence of triethylamine. It has been shown to be not metabolized, but excreted unchanged in urine.</p>Formule :C13H23NO8SDegré de pureté :Min. 95%Couleur et forme :Colourless LiquidMasse moléculaire :353.39 g/molN,N'''-(Dithia-2,1-ethanediyl)bis-(N'-cyano-N''-methyl)guanidine
CAS :<p>N,N'''-(Dithia-2,1-ethanediyl)bis-(N'-cyano-N''-methyl)guanidine is a metabolite of guanidine. It is a synthetic compound that is used as an analytical reference standard and impurity in pharmaceutical products. It is also used to create an impurity standard for HPLC analysis. This compound has been found in natural sources such as plants and animal tissues, but it can also be synthesized in the lab. The CAS number for this substance is 74886-59-2.</p>Formule :C10H18N8S2Degré de pureté :Min. 95%Couleur et forme :White PowderMasse moléculaire :314.43 g/mol8-Fluoro-2,2-dimethyl-9-(4-methyl-1-piperazinyl)-6-oxo-2H,6H-oxazolo[5,4,3-ij]quinoline-5-carboxylic acid
CAS :<p>8-Fluoro-2,2-dimethyl-9-(4-methyl-1-piperazinyl)-6-oxo-2H,6H-oxazolo[5,4,3-ij]quinoline-5-carboxylic acid is a synthetic drug product. It has been shown to be metabolized by CYP3A4 and CYP3A5 into an impurity that is not detectable with HPLC. 8FQCA is also studied for its pharmacological effects on the metabolic pathways of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and cyclooxygenase 2 (COX2).</p>Formule :C18H20FN3O4Degré de pureté :Min. 95%Masse moléculaire :361.37 g/mol2-Mercaptobenzimidazole
CAS :<p>2-Mercaptobenzimidazole is a chemical compound that can be used for the treatment of infectious diseases. It has been shown to have antioxidative properties and inhibit the growth of bacteria. 2-Mercaptobenzimidazole also has an effect on human serum, which may be due to its ability to bind with proteins in serum and form hydrogen bonds. 2-Mercaptobenzimidazole is stable at high temperatures and has been shown as an effective antimicrobial agent against gram positive and gram negative bacteria.</p>Formule :C7H6N2SDegré de pureté :Min. 99 Area-%Couleur et forme :White/Off-White SolidMasse moléculaire :150.19 g/mol[[5-[[(2-Aminoethyl)thio]methyl]furan-2-yl]methyl]dimethylamine
CAS :<p>[[5-[[(2-Aminoethyl)thio]methyl]furan-2-yl]methyl]dimethylamine is a metabolite of the drug [[5-[[(2-Aminoethyl)thio]methyl]furan-2-yl]methyl]dimethylamine. It is found in the urine of patients taking [[5-[[(2-Aminoethyl)thio]methyl]furan-2-yl]methyl]dimethylamine and has been used as an impurity standard for [[5-[(2-(Aminoethyl)thio]-methyl]-furan-2ylmethyl]-dimethylamine.</p>Formule :C10H18N2OSDegré de pureté :Min. 95%Couleur et forme :Colorless Clear LiquidMasse moléculaire :214.33 g/mol3-[4-(2-Methoxyethyl)phenoxy]-1,2-propanediol
CAS :<p>3-[4-(2-Methoxyethyl)phenoxy]-1,2-propanediol is a synthetic intermediate. It is metabolized from the drug product 3-[4-(2-Methoxyethyl)phenoxy]propionic acid and may be used as an impurity standard for this compound. This chemical is a high purity, pharmacopoeia grade material that is suitable for use in drug development and pharmaceutical research. 3-[4-(2-Methoxyethyl)phenoxy]-1,2-propanediol has a natural origin and can be produced synthetically or through biotransformation of other compounds.</p>Formule :C12H18O4Degré de pureté :Min. 96 Area-%Couleur et forme :White Off-White PowderMasse moléculaire :226.27 g/mol5-Methoxy-2-[[(4-Chloro-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-5-methoxy-1H-benzimidazole
CAS :<p>5-Methoxy-2-[(4-chloro-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-5-methoxy-1H benzimidazole is a synthetic drug product. It has been used as a positive control in metabolism studies and as an impurity standard. 5-Methoxy 2-[(4-chloro 3,5 dimethyl 2 pyridinyl)methyl]sulfinyl]-5 methoxy 1H benzimidazole is also a metabolite of the active pharmaceutical ingredient (API) which is used to develop drugs. This chemical is synthesized by custom synthesis and can be obtained at high purity levels. The metabolite of this compound is 5 methoxy 2-[(4 chloro 3,5 dimethyl 2 pyridinyl)methyl]sulfonyl]-5 methoxy 1H benzimidazole.</p>Formule :C16H16ClN3O2SDegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :349.84 g/mol3-Oxo-4-aza-5a-androst-1-ene-17b-carboxylic acid
CAS :<p>3-Oxo-4-aza-5a-androst-1-ene-17b-carboxylic acid is a covalently bonded prodrug that is metabolized to its active form, finasteride, in the body. It has been shown to have physiological activities such as skin permeation and cell growth. 3-Oxo-4-aza-5a-androst-1-ene 17b carboxylic acid also has immunotherapy properties and can be conjugated with other compounds for use in cancer treatment.</p>Formule :C19H27NO3Degré de pureté :Min. 98 Area-%Couleur et forme :PowderMasse moléculaire :317.42 g/molN-[2-[[[5(Dimethylamino)methyl]-2-furanyl]thio]ethyl]-N'-methyl-2-nitro-2,2-ethendiamine, S-oxide
CAS :<p>N-[2-[[[5(Dimethylamino)methyl]-2-furanyl]thio]ethyl]-N'-methyl-2,2-ethendiamine, S-oxide is a chemical compound that has been shown to be an effective inhibitor of the metabolism of many drugs in rat liver microsomes. This drug is used as an analytical method in urine samples to study the clinical relevance of n-oxide metabolites and their effects on drug interactions. N-[2-[[[5(Dimethylamino)methyl]-2-furanyl]thio]ethyl]-N'-methyl-2,2-ethendiamine, S-oxide has been shown to have optimum concentration at 0.1 mM in wastewater treatment systems. The kinetic data for this compound were obtained using a model system with low bioavailability.</p>Formule :C13H22N4O4SDegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :330.4 g/mol[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-2-furanyl-methanone
CAS :<p>Leflunomide is a drug that belongs to the class of pyridones. It is used in the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, and ankylosing spondylitis. Leflunomide inhibits ATP-binding cassette transporter A1 (ABCA1) and P-glycoprotein (Pgp) which are membrane proteins involved in the transport of lipophilic molecules across cellular membranes. Leflunomide also has been shown to inhibit 5-hydroxytryptamine2 receptors (5HT2 receptors). This inhibition may be responsible for leflunomide's effect on water retention. Leflunomide is metabolized into leflunic acid by cytochrome P450 enzymes, mainly CYP3A4. The activity of leflunic acid is similar to that of leflunomide.</p>Formule :C19H21N5O4Degré de pureté :Min. 95%Masse moléculaire :383.4 g/molN,N-Dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl) propanamine tartrate
CAS :<p>N,N-Dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl) propanamine tartrate (DMNPA) is a synthetic compound with the molecular formula C14H17NO. DMNPA is used as an analytical reference standard for the quantification of N,N-dimethyl-3-(1-naphthalenyloxy)-3-(2thienyl) propanamine HCl by HPLC. DMNPA has been shown to be a metabolite of the drug product, where it is formed from oxidation of the parent drug.</p>Formule :C19H21NOS·C4H6O6Degré de pureté :Min. 95%Masse moléculaire :461.53 g/molMontelukast ketone impurity
CAS :<p>The impurity (2,6-dichlorobenzaldehyde) is a metabolite of montelukast. It is an analytical impurity that has been quantified in the drug product and has also been found to be present in the synthetic process. The impurity standard was developed using HPLC. It can be used as a high purity reference material for pharmacopoeia and custom synthesis.</p>Formule :C29H26ClNO2Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :455.97 g/mol(1R,4S)-N-Desmethyl sertraline hydrochloride
CAS :<p>Sertraline metabolite</p>Formule :C16H16Cl3NDegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :328.66 g/molApixaban Impurity 2
CAS :<p>Apixaban impurity 2 is a drug product that is used as an impurity standard in the research and development of drugs. It is also used as a synthetic intermediate in the synthesis of other drugs. Apixaban impurity 2 has been shown to be pharmacologically active, with the ability to inhibit bacterial growth by binding to DNA-dependent RNA polymerase. This compound is not toxic to mammalian cells at high concentrations, but has been shown to have some effects on the central nervous system, including depression of spontaneous motor activity and decrease in locomotor activity. Apixaban Impurity 2 is soluble in acetone and chloroform, but insoluble in water. The molecular weight of this compound is not known, but it can be determined using HPLC. Apixaban Impurity 2 has CAS number 2187409-01-2 and its molecular formula is C21H22N2O4S.</p>Formule :C25H28N6O4Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :476.53 g/mol2,6-Dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ethyl methyl ester
CAS :<p>2,6-Dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ethyl methyl ester (DMPD) is an enzyme inhibitor that belongs to the group of metabolic inhibitors. This agent is used for the preparation of samples for analysis by chromatography and mass spectrometry. DMPD inhibits the activity of enzymes involved in drug metabolism, including CYP2C8, CYP2C9, CYP2D6, and CYP3A4. The matrix effect can be minimized by using a more acidic sample preparation. The immunosuppressant properties of DMPD have been shown in mice by inhibiting T cell activation and proliferation in vitro.</p>Formule :C18H18N2O6Degré de pureté :Min. 95%Couleur et forme :Pale yellow to yellow solid.Masse moléculaire :358.35 g/molOmeprazole impurity F and G
CAS :<p>Omeprazole is a proton pump inhibitor that inhibits the H+/K+-ATPase enzyme in gastric parietal cells. Omeprazole impurity F and G are metabolites of omeprazole. Omeprazole impurity F is a metabolite of omeprazole that forms by oxidation of the methylthio group in omeprazole to form a sulfoxide. Omeprazole impurity G is formed by hydrolysis of the methylthio group in omeprazole to form an alcohol. The purity of this product is high and can be custom synthesized based on customer's needs. It is also available as an HPLC standard or as an API impurity for use in metabolism studies.</p>Formule :C16H13N3O2SDegré de pureté :Min. 95%Couleur et forme :Red PowderMasse moléculaire :311.36 g/mol2-Hydroxybenzimidazole
CAS :<p>2-Hydroxybenzimidazole is a benzimidazole compound that is used in the treatment of nervous system diseases. It has been shown to have anti-inflammatory properties and can be used in the treatment of syncytial virus infection. 2-Hydroxybenzimidazole inhibits the production of reactive oxygen species and nitric oxide, which are involved in neurodegenerative disorders. The mechanism of action for 2-Hydroxybenzimidazole involves the formation of hydrogen bonds with hydroxyl groups on proteins. It also has been shown to reduce locomotor activity and increase sleep time in mice, which may be due to inhibition of acetylcholine release from cholinergic neurons.</p>Formule :C7H6N2ODegré de pureté :Min. 97.5 Area-%Couleur et forme :Off-White PowderMasse moléculaire :134.14 g/molRopinirole
CAS :<p>Ropinirole, D2-like agonist, no D1 affinity, Ki 29 nM for D2, treats Parkinson's.</p>Formule :C16H24N2ODegré de pureté :99.68%Couleur et forme :SolidMasse moléculaire :260.38Tafenoquine
CAS :<p>Tafenoquine (WR 238605) is an antimalarial prophylactic agent with schizonticidal activity, useful in hemolytic anemia research.</p>Formule :C24H28F3N3O3Degré de pureté :99.56%Couleur et forme :SolidMasse moléculaire :463.49Varenicline
CAS :<p>Varenicline (CP 526555) is a selective partial agonist of the α4β2 nAChR and a full agonist of the α3β4 nAChR and α7 nAChR.</p>Formule :C13H13N3Degré de pureté :99.76%Couleur et forme :SolidMasse moléculaire :211.26Pitavastatin
CAS :<p>Pitavastatin (NK-104) is an HMG-CoA reductase inhibitor with hypocholesterolemic and neuroprotective activities.</p>Formule :C25H24FNO4Degré de pureté :97.17%Couleur et forme :SolidMasse moléculaire :421.462-Thiophenecarbonitrile
CAS :Formule :C5H3NSDegré de pureté :97%Couleur et forme :LiquidMasse moléculaire :109.152,6-Dichloro-4-nitropyridine
CAS :Formule :C5H2Cl2N2O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :192.986-Chloro-5-fluoropyridin-3-amine
CAS :Formule :C5H4ClFN2Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :146.553-(Trifluoromethyl)-1H-pyrazol-5-amine
CAS :Formule :C4H4F3N3Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :151.0922-Aminomethylquinoline
CAS :Formule :C10H10N2Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :158.2042,5-Dioxopyrrolidin-1-yl 6-(2-(propan-2-ylidene)hydrazinyl)nicotinate
CAS :Formule :C13H14N4O4Degré de pureté :97%Masse moléculaire :290.2792-(Trifluoromethyl)phenothiazine
CAS :Formule :C13H8F3NSDegré de pureté :98%Couleur et forme :Yellow powderMasse moléculaire :267.273-(2-Pyridyldithio)propanoic acid
CAS :Formule :C8H9NO2S2Degré de pureté :95%Couleur et forme :Liquid, No data available.Masse moléculaire :215.291-(3-Bromo-phenyl)-1H-pyrazole
CAS :Formule :C9H7BrN2Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :223.0732,4-Dichloropyridine
CAS :Formule :C5H3Cl2NDegré de pureté :98%Couleur et forme :LiquidMasse moléculaire :147.993-Bromo-4-methylpicolinonitrile
CAS :Formule :C7H5BrN2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :197.035(R)-4,6-Dichloro-N-(2-fluoro-3-hydroxy-3-methylbutyl)nicotinamide
CAS :Degré de pureté :98%Masse moléculaire :295.142-(Difluoromethoxy)pyridin-3-amine
CAS :Formule :C6H6F2N2ODegré de pureté :97%Masse moléculaire :160.1242-Cyanopyrazine
CAS :Formule :C5H3N3Degré de pureté :98%Couleur et forme :Liquid, ClearMasse moléculaire :105.14-Ethynylpyridin-2-amine
CAS :Formule :C7H6N2Degré de pureté :98%Couleur et forme :Liquid, No data available.Masse moléculaire :118.1392,6-Dibromo-3-hydroxypyridine
CAS :Formule :C5H3Br2NODegré de pureté :95%Couleur et forme :SolidMasse moléculaire :252.8932-Chloro-5-pyridinecarboxaldehyde
CAS :Formule :C6H4ClNODegré de pureté :97%Couleur et forme :SolidMasse moléculaire :141.552-Methyl-5-formylpyridine
CAS :Formule :C7H7NODegré de pureté :95%Couleur et forme :LiquidMasse moléculaire :121.139(R)-4-Benzyl-3-hydroxymethylmorpholine
CAS :Formule :C12H17NO2Degré de pureté :97%Couleur et forme :No data available.Masse moléculaire :207.273[2,2′-Bipyridine]-6-carbaldehyde
CAS :Formule :C11H8N2ODegré de pureté :95%Couleur et forme :No data available.Masse moléculaire :184.1982-Bromo-4-cyanopyridine
CAS :Formule :C6H3BrN2Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :183.0082,5-Dimethyl-2 H -pyrazole-3-carboxylic acid hydrazide
CAS :Formule :C6H10N4ODegré de pureté :97%Couleur et forme :Solid, No data available.Masse moléculaire :154.1735-Chloro-4-(trifluoromethyl)pyridin-2-amine
CAS :Formule :C6H4ClF3N2Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :196.562-Fluoro-5-methoxynicotinaldehyde
CAS :Formule :C7H6FNO2Degré de pureté :98%Masse moléculaire :155.1282-Morpholinothiazole-4-carbaldehyde
CAS :Formule :C8H10N2O2SDegré de pureté :98%Masse moléculaire :198.244-Chloronicotinonitrile
CAS :Formule :C6H3ClN2Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :138.553-Thiophenecarboxylic acid hydrazide
CAS :Formule :C5H6N2OSDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :142.185-bromoquinolin-6-amine
CAS :Formule :C9H7BrN2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :223.0732,6-Dimethoxy pyridine
CAS :Formule :C7H9NO2Degré de pureté :96%Couleur et forme :LiquidMasse moléculaire :139.1541-(4-(Trifluoromethoxy)phenyl)-1H-pyrazole-4-carboxylic acid
CAS :Degré de pureté :98%Masse moléculaire :272.18301392-Pyrazol-1-yl-ethanol
CAS :Formule :C5H8N2ODegré de pureté :97%Couleur et forme :LiquidMasse moléculaire :112.1321,3,5-Triallyl-1,3,5-triazinane-2,4,6-trione (stabilised with BHT)
CAS :Formule :C12H15N3O3Degré de pureté :97%(stabilized with BHT)Couleur et forme :Solid, CrystallineMasse moléculaire :249.273-Bromo-5-ethylpyridine
CAS :Formule :C7H8BrNDegré de pureté :98%Couleur et forme :Liquid, ClearMasse moléculaire :186.0523-Amino-2-chloro-4-methylpyridine
CAS :Formule :C6H7ClN2Degré de pureté :95%Couleur et forme :Crystalline PowderMasse moléculaire :142.592-(2-Hydroxyethyl)quinoline
CAS :Formule :C11H11NODegré de pureté :95%Couleur et forme :SolidMasse moléculaire :173.2152-Bromoquinoline
CAS :Formule :C9H6BrNDegré de pureté :97%Couleur et forme :SolidMasse moléculaire :208.0583-Methyl-4-nitro-1H-pyrazole
CAS :Formule :C4H5N3O2Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :127.1034-Chloro-6,7-dimethoxy-quinoline
CAS :Formule :C11H10ClNO2Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :223.66Methyl 3-amino-6-bromopyrazine-2-carboxylate
CAS :Formule :C6H6BrN3O2Degré de pureté :95%Couleur et forme :Solid, Yellow powderMasse moléculaire :232.0375-Methoxy-1H-pyrazol-3-amine hydrochloride
CAS :Formule :C4H8ClN3ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :149.585-(5-Methyl-furan-2-yl)-2 H -pyrazole-3-carboxylic acid
CAS :Formule :C9H8N2O3Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :192.1744-Bromo-2-(tert-butyl)pyridine
CAS :Formule :C9H12BrNDegré de pureté :98%Couleur et forme :LiquidMasse moléculaire :214.106(1H-PYRAZOL-3-YL)-ACETIC ACID ETHYL ESTER
CAS :Formule :C7H10N2O2Degré de pureté :95%Couleur et forme :LiquidMasse moléculaire :154.169(5-thien-2-yl-1H-pyrazol-3-yl)methanol
CAS :Formule :C8H8N2OSDegré de pureté :97%Masse moléculaire :180.233-(4-(tert-Butyl)pyridin-1-ium-1-yl)propane-1-sulfonate
CAS :Degré de pureté :98%Masse moléculaire :257.35000611-Bromoisoquinoline
CAS :Formule :C9H6BrNDegré de pureté :95%Couleur et forme :SolidMasse moléculaire :208.0585-chloro-3-methyl-1-phenyl-1H-pyrazole-4-carboxylic acid
CAS :Formule :C11H9ClN2O2Degré de pureté :95%Masse moléculaire :236.664,6-Dichloro-2-methylnicotinic acid
CAS :Formule :C7H5Cl2NO2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :206.024-(Ethoxycarbonyl)-1-methyl-1H-pyrazole-5-carboxylic acid
CAS :Formule :C8H10N2O4Degré de pureté :98%Masse moléculaire :198.178(S)-2-([2,2′-Bipyridin]-6-yl)-4-(tert-butyl)-4,5-dihydrooxazole
CAS :Degré de pureté :95%Masse moléculaire :281.35900881-(3-Pyridyl)-3-(dimethylamino)-2-propen-1-one
CAS :Formule :C10H12N2ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :176.2192,6-BIS((R)-4-ETHYL-4,5-DIHYDROOXAZOL-2-YL)PYRIDINE
CAS :Degré de pureté :97%Masse moléculaire :273.33599852,6-Dimethylpyridin-4-ylamine
CAS :Formule :C7H10N2Degré de pureté :95%Couleur et forme :White powderMasse moléculaire :122.171TERT-BUTYL (2-(4-BROMO-1H-PYRAZOL-1-YL)ETHYL)CARBAMATE
CAS :Degré de pureté :95%Masse moléculaire :290.16101071-Methyl-1H-pyrazole-5-boronic acid pinacol ester
CAS :Formule :C10H17BN2O2Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :208.071H-Pyrazole-3-carboxylic acid
CAS :Formule :C4H4N2O2Degré de pureté :98%Couleur et forme :Solid, Crystalline Powder or PowderMasse moléculaire :112.088(2-Oxo-1,2-dihydropyridin-3-yl)boronic acid
CAS :Formule :C5H6BNO3Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :138.92(1,5-Dimethyl-1H-pyrazol-4-yl)boronic acid
CAS :Formule :C5H9BN2O2Degré de pureté :96%Masse moléculaire :139.952-Chloro-6-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
CAS :Formule :C12H17BClNO2Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :253.533-Bromo-6-chloro-2-fluoropyridine
CAS :Formule :C5H2BrClFNDegré de pureté :95%Couleur et forme :Solid, Low Melting SolidMasse moléculaire :210.43
![8-Fluoro-2,2-dimethyl-9-(4-methyl-1-piperazinyl)-6-oxo-2H,6H-oxazolo[5,4,3-ij]quinoline-5-carboxyl…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIF182900.webp&w=3840&q=75)
![[[5-[[(2-Aminoethyl)thio]methyl]furan-2-yl]methyl]dimethylamine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIA57830.webp&w=3840&q=75)
![3-[4-(2-Methoxyethyl)phenoxy]-1,2-propanediol](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIM63783.webp&w=3840&q=75)
![5-Methoxy-2-[[(4-Chloro-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-5-methoxy-1H-benzimidazole](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIM57916.webp&w=3840&q=75)
![N-[2-[[[5(Dimethylamino)methyl]-2-furanyl]thio]ethyl]-N'-methyl-2-nitro-2,2-ethendiamine, S-oxide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FID57862.webp&w=3840&q=75)
![[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-2-furanyl-methanone](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIA63850.webp&w=3840&q=75)
![[2,2′-Bipyridine]-6-carbaldehyde](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF238405.webp&w=3840&q=75)
![[2,2′-Bipyridine]-6,6′-dicarbaldehyde](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF608673.webp&w=3840&q=75)
![[3,3′-Bipyridine]-6-carboxylic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF904891.webp&w=3840&q=75)
![(S)-2-([2,2′-Bipyridin]-6-yl)-4-(tert-butyl)-4,5-dihydrooxazole](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF864641.webp&w=3840&q=75)
